gliptin and glp-1 Insights into the Roles of GLP-1, DPP-4, SGLT2 at the Crossroads of Cardiovascular, Renal, and Metabolic Pathophysiology Expert Opinion: Optimum Clinical Approach

The ability of peripherally circulating GLP-1 and GLP-1RAs to breach the blood-brain barrier remains uncertain

he is paid a medical advisor for digital healthcare companies in the dementia space (Five Lives SAS, Cognetivity Ltd, Cognes Ltd)

Proton Pump Inhibitors (PPIs) Medications like omeprazole (Prilosec) or esomeprazole (Nexium) are the strongest acid reducers available over-the-counter

It can be very confusing to sort out whats applicable to you, he says

doi: 10.1016/j.conb.2025.103021, 49

the VEGFR2-blocking, human anti-VEGF antibody therapeutics of the invention will be operatively attached to cytotoxic, cytostatic or otherwise anti-cellular agents that have the ability to kill or suppress the growth or cell division of endothelial cells